These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26001058)

  • 1. Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.
    Morris DL
    Mol Endocrinol; 2015 Jul; 29(7):946-62. PubMed ID: 26001058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and islet inflammation in type 2 diabetes.
    Eguchi K; Manabe I
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():152-8. PubMed ID: 24003932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased number of islet-associated macrophages in type 2 diabetes.
    Ehses JA; Perren A; Eppler E; Ribaux P; Pospisilik JA; Maor-Cahn R; Gueripel X; Ellingsgaard H; Schneider MK; Biollaz G; Fontana A; Reinecke M; Homo-Delarche F; Donath MY
    Diabetes; 2007 Sep; 56(9):2356-70. PubMed ID: 17579207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
    Westwell-Roper CY; Ehses JA; Verchere CB
    Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages, cytokines and beta-cell death in Type 2 diabetes.
    Ehses JA; Böni-Schnetzler M; Faulenbach M; Donath MY
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):340-2. PubMed ID: 18481953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization.
    Cucak H; Grunnet LG; Rosendahl A
    J Leukoc Biol; 2014 Jan; 95(1):149-60. PubMed ID: 24009176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
    Montolio M; Biarnés M; Téllez N; Escoriza J; Soler J; Montanya E
    J Endocrinol; 2007 Jan; 192(1):169-77. PubMed ID: 17210754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.
    Grzesik WJ; Nadler JL; Machida Y; Nadler JL; Imai Y; Morris MA
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E387-95. PubMed ID: 25532042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.
    Levetan C
    J Diabetes; 2010 Jun; 2(2):76-84. PubMed ID: 20923488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
    Hull RL; Westermark GT; Westermark P; Kahn SE
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3629-43. PubMed ID: 15292279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction.
    Westwell-Roper C; Dai DL; Soukhatcheva G; Potter KJ; van Rooijen N; Ehses JA; Verchere CB
    J Immunol; 2011 Sep; 187(5):2755-65. PubMed ID: 21813778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.
    Westwell-Roper C; Nackiewicz D; Dan M; Ehses JA
    Immunol Cell Biol; 2014 Apr; 92(4):314-23. PubMed ID: 24492799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat.
    Homo-Delarche F; Calderari S; Irminger JC; Gangnerau MN; Coulaud J; Rickenbach K; Dolz M; Halban P; Portha B; Serradas P
    Diabetes; 2006 Jun; 55(6):1625-33. PubMed ID: 16731824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet inflammation in type 2 diabetes and physiology.
    Eguchi K; Nagai R
    J Clin Invest; 2017 Jan; 127(1):14-23. PubMed ID: 28045399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative modification, inflammation and amyloid in the normal and diabetic cat pancreas.
    Herndon AM; Breshears MA; McFarlane D
    J Comp Pathol; 2014 Nov; 151(4):352-62. PubMed ID: 25124331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy.
    Mizukami H
    Pathol Int; 2024 Aug; 74(8):438-453. PubMed ID: 38888200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore.
    Lyon J; Manning Fox JE; Spigelman AF; Kim R; Smith N; O'Gorman D; Kin T; Shapiro AM; Rajotte RV; MacDonald PE
    Endocrinology; 2016 Feb; 157(2):560-9. PubMed ID: 26653569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-associated macrophages in type 2 diabetes.
    Richardson SJ; Willcox A; Bone AJ; Foulis AK; Morgan NG
    Diabetologia; 2009 Aug; 52(8):1686-8. PubMed ID: 19504085
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulitis in type 2 diabetes.
    Böni-Schnetzler M; Ehses JA; Faulenbach M; Donath MY
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():201-4. PubMed ID: 18834448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.